OneAscent Financial Services’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-704
| Closed | -$294K | – | 398 |
|
|
2024
Q1 | $294K | Sell |
704
-49
| -7% | -$20.5K | 0.03% | 295 |
|
|
2023
Q4 | $306K | Sell |
753
-234
| -24% | -$95.1K | 0.04% | 262 |
|
|
2023
Q3 | $343K | Sell |
987
-17
| -2% | -$5.91K | 0.09% | 166 |
|
|
2023
Q2 | $353K | Buy |
1,004
+119
| +13% | +$41.8K | 0.16% | 72 |
|
|
2023
Q1 | $279K | Sell |
885
-167
| -16% | -$52.6K | 0.11% | 122 |
|
|
2022
Q4 | $304K | Buy |
1,052
+9
| +0.9% | +$2.6K | 0.13% | 111 |
|
|
2022
Q3 | $302K | Sell |
1,043
-429
| -29% | -$124K | 0.12% | 118 |
|
|
2022
Q2 | $415K | Buy |
1,472
+505
| +52% | +$142K | 0.19% | 93 |
|
|
2022
Q1 | $252K | Buy |
+967
| New | +$252K | 0.18% | 98 |
|
|
2021
Q1 | – | Sell |
-1,040
| Closed | -$246K | – | 162 |
|
|
2020
Q4 | $246K | Sell |
1,040
-940
| -47% | -$222K | 0.26% | 94 |
|
|
2020
Q3 | $539K | Buy |
+1,980
| New | +$539K | 0.28% | 66 |
|